2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary

TF Chao, B Joung, Y Takahashi, TW Lim… - Thrombosis and …, 2022 - thieme-connect.com
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …

[HTML][HTML] Post-acute COVID-19 syndrome

A Nalbandian, K Sehgal, A Gupta, MV Madhavan… - Nature medicine, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen
responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has resulted in …

Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among …

S Mazloomzadeh, S Khaleghparast, B Ghadrdoost… - Jama, 2021 - jamanetwork.com
Importance Thrombotic events are commonly reported in critically ill patients with COVID-19.
Limited data exist to guide the intensity of antithrombotic prophylaxis. Objective To evaluate …

Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis

D Jiménez, A García-Sanchez, P Rali, A Muriel… - Chest, 2021 - Elsevier
Background Individual studies have reported widely variable rates for VTE and bleeding
among hospitalized patients with coronavirus disease 2019 (COVID-19). Research Question …

COVID-19: from an acute to chronic disease? Potential long-term health consequences

V Higgins, D Sohaei, EP Diamandis… - Critical reviews in …, 2021 - Taylor & Francis
Abstract Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Despite pulmonary impairments being the most …

Extrapulmonary manifestations of COVID-19

A Gupta, MV Madhavan, K Sehgal, N Nair… - Nature medicine, 2020 - nature.com
Although COVID-19 is most well known for causing substantial respiratory pathology, it can
also result in several extrapulmonary manifestations. These conditions include thrombotic …

The coagulopathy, endotheliopathy, and vasculitis of COVID-19

T Iba, JM Connors, JH Levy - Inflammation Research, 2020 - Springer
Abstract Background COVID-19-associated coagulopathy (CAC) characterized by the
elevated D-dimer without remarkable changes of other global coagulation markers is …

Registry of arterial and venous thromboembolic complications in patients with COVID-19

G Piazza, U Campia, S Hurwitz, JE Snyder… - Journal of the American …, 2020 - jacc.org
Background Cardiovascular complications, including myocardial infarction, ischemic stroke,
and pulmonary embolism, represent an important source of adverse outcomes in …

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review

AH Talasaz, P Sadeghipour, H Kakavand… - Journal of the American …, 2021 - jacc.org
Endothelial injury and microvascular/macrovascular thrombosis are common
pathophysiological features of coronavirus disease-2019 (COVID-19). However, the optimal …

[HTML][HTML] Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19

C Radermecker, N Detrembleur, J Guiot… - Journal of Experimental …, 2020 - rupress.org
Infection with SARS-CoV-2 is causing a deadly and pandemic disease called coronavirus
disease–19 (COVID-19). While SARS-CoV-2–triggered hyperinflammatory tissue-damaging …